Source: Virtual Congress 2021 – COVID - 19 risk predictions



Rating:

Share or cite this content

Citations should be made in the following way:
L. Akulkina (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation). Association between type of antihyperglycemic therapy and COVID-19 outcomes in patients with type 2 DM. 3653

Member's Comments

No comment yet.

Related content which might interest you: Association between type 2 diabetes and respiratory symptoms Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Death rate of COPD patients and combination with type 2 diabetes Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Association between bronchial reactivity and diabetes type 2 Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Insulin therapy increases airway responsiveness in type 2 diabetes patients Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010 Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Association between type 2 diabetes, prediabetes and lung function: Results from the KORA cohort Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Respiratory muscle function in type 2 diabetes mellitus Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma Source: Eur Respir J, 58 (4) 2004605; 10.1183/13993003.04605-2020 Year: 2021